Inventors:
John A. McCauley - Maple Glen PA, US
Thomas J. Greshock - Collegeville PA, US
John Sanders - Collegeville PA, US
Heather H. Stevenson - Conshohocken PA, US
Jonathan T. Kern - Souderton PA, US
Ronald K. Chang - Oreland PA, US
International Classification:
C07D 409/14
C07D 417/14
C07F 7/10
C07D 409/04
US Classification:
514 63, 5483644, 514406, 548136, 514363, 548110, 5142102, 544371, 51425407, 544140, 5142335, 5462754, 514337, 546202, 514324
Abstract:
Disclosed are compounds of Formula I: and the pharmaceutically acceptable salts thereof, wherein “A” is S—; —SO—, —SO—, —O— or NR, and R, and Rthrough Rare defined herein. Also disclosed are pharmaceutical formulations comprising a compound of Formula I and methods of treating, managing, or ameliorating diseases amenable to treatment, management, or amelioration by inhibition of LRRK2 kinase activity, for example, Parkinson's disease.